Ask Christine about: medical devices (Rosenman Institute), venture funds & early-stage investing, corporate partnerships & sponsorships
Christine Winoto, Director of the Rosenman Institute and Deputy Director at QB3, manages the Life Science Pitch Summit program, the QB3-JPMorgan Chase program for women and diversity in life sciences, and QB3 operations. Before joining QB3, she developed business plan and marketing strategy and capital planning for Kaiser Permanente and managed business development at Genencor. In addition to consulting for startups and venture capital, she has held R&D and operations positions in medical device companies including Physiometrix (IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine also worked in mergers and acquisitions for a European investment bank. Christine holds an MBA from Erasmus University in the Netherlands and a BS in food chemistry from the University of Wisconsin, Madison.